CDMO- Generics/OTCs in Tablets, Capsules, Granules...
Product Description
Visum Pharmaceutical Co., Ltd
-
Country/Region:China
-
On CPHI since:2022
-
Certificates:2
-
Employees:250 - 499
Company types
Primary activities
Categories
Specifications
Visum Pharmaceutical Co., Ltd
-
Country/Region:China
-
On CPHI since:2022
-
Certificates:2
-
Employees:250 - 499
Company types
Primary activities
More Products from Visum Pharmaceutical Co., Ltd (6)
-
Product Analytical Method Develpment and Validation
Providing Analytical method development, validation and stability study from Phase I-III to commercial prodcution and registration. -
Product Clinical Supply Manufacturing
NCEs • Phase I-III formulation process development and clinical supply manufacturing Generic drugs
• BE sample manufacturing • Process Optimization -
.png)
Product Commercial Manufacturing (CMO)
Standards: • US, EU, China, WHO Commercial Scales
• Tablets: 3 billion/year • Capsules: 500 million/year • Oral solution: 100 million/year • Ointment: 50 million/year • Granules: 300 million/year -
Product Formulation Development
NCEs • Phase I-III formulation and development Generic Drugs • Pharmaceutical, analytical method development and process study -
Product Metoprolol Succinate Extended-Release Tablets
Metoprolol Succinate Extended-Release Tablets is a beta 1-selevitve adrenoceptor blocking agent, which can reduce heart rate, myocardial contractility, blood pressure, antagonize the toxicity of catecholamine adreneric transmitters, and has good cardiovascular protection. It is widely used in cardiov... -
Product Paroxetine Extended-Release Tablets
For the treatment of Major Depressive Disorder (MDD), Panic Disorder (PD), Social Anxiety Disorder (SAD) and Premenstrual Dysphoric Disorder (PMDD).